CLEC9A and fibrosarcoma: Therefore, we assessed whether mouse primary fibrosarcomas from DNGR-1-deficient versus DNGR-1-sufficient mice might differ in a subset of predicted strong neoantigens specifically derived from F-actin binding proteins (FABP) (n = 88, Extended Data Table 1).